Table 3. Characterization of CD presentation in patients with T1D.
Age at diagnosis of CD (years) | ||
Mean | 10,50 | |
SD/Min-Max | 2,65/7,0-13,0 | |
Follow-up between T1D and CD diagnosis (years) | ||
Mean | 3,40 | |
SD/Min-Max | 3,32/0,08-7,25 | |
HLA screening, n (%) | ||
Registered | 3 (75%) | |
HLA DQ2 | 1 (33,3%) | |
HLA DQ2/DQ8 | 2 (66,7%) | |
Positive IgA antibodies (at diagnosis), n (%) | ||
Anti-EmA IgA | 0 (0%) | |
Anti-tTG IgA | 1 (33,3%) | |
Anti-EmA e Anti-tTG IgA | 2 (66,7%) | |
Positive IgG antibodies (at diagnosis), n (%) | ||
Anti-EmA e Anti-tTG IgG | 100%, n = 1 | |
Biopsy histology n (%) | ||
3B | 2 (50%) | |
3C | 2 (50%) | |
GI symptoms n (%) | 0 (0%) | |
Non-GI symptoms n (%) | 4 (100%) | |
Poor weight gain | 1 (25%) | |
Nail changes | 1 (25%) | |
Iron deficient anemia | 1 (25%) | |
Poor weight gain and hypoglycemia | 1 (25%) |